Lawrence Steinman
Fondateur chez PASITHEA THERAPEUTICS CORP.
Fortune : 571 447 $ au 30/04/2024
Profil
Lawrence J.
Steinman is the founder of Nuon Therapeutics, Inc. (founded in 2006), Neurocrine Biosciences, Inc. (founded in 1997), Bayhill Therapeutics, Inc. (founded in 2001), Atreca, Inc. (founded in 2010), Tolerion, Inc. (founded in 2013), and Pasithea Therapeutics Corp.
(founded in 2020).
Dr. Steinman is also the founder of Drumroll Health, Inc., Steinman Laboratory, Katexco Pharmaceuticals Corp., and 180 Life Sciences Corp.
Dr. Steinman's current job(s) include being the Co-Chairman at CannBioRex Pharmaceuticals Corp.
(since 2018), Co-Chairman at 180 Life Corp.
(since 2019), Lead Independent Director at BioAtla, Inc. (since 2016), Independent Director at Pharnext SA (since 2020), Director at Himalaya Therapeutics, Member of the National Academy of Sciences, Member of the National Academy of Medicine (United States), and Professor at Stanford University (since 2001).
Dr. Steinman's former job(s) include being the Co-Executive Chairman at KBL Merger Corp.
IV, Director at Centocor, Inc. (from 1989 to 1998), and Director at Neuronyx, Inc.Dr. Steinman's education history includes an undergraduate degree from Dartmouth College (1968), a doctorate from Hasselt University (2008), a doctorate from Harvard Medical School (1973), and a doctorate from the University of Buenos Aires School of Medicine (2022).
Dr. Steinman is also the founder of Drumroll Health, Inc., Steinman Laboratory, Katexco Pharmaceuticals Corp., and 180 Life Sciences Corp.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/04/2024 | 66 358 ( 6,37% ) | 480 432 $ | 30/04/2024 | |
BIOATLA, INC.
0,08% | 19/12/2023 | 38 459 ( 0,08% ) | 86 533 $ | 30/04/2024 |
180 LIFE SCIENCES CORP.
0,30% | 29/04/2024 | 2 534 ( 0,30% ) | 4 483 $ | 30/04/2024 |
Postes actifs de Lawrence Steinman
| Sociétés | Poste | Début |
|---|---|---|
| BIOATLA, INC. | Directeur/Membre du Conseil | 01/01/2016 |
| 180 LIFE SCIENCES CORP. | Fondateur | - |
| PHARNEXT SCA | Directeur/Membre du Conseil | 17/07/2020 |
| PASITHEA THERAPEUTICS CORP. | Fondateur | 01/05/2020 |
Katexco Pharmaceuticals Corp.
 Katexco Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Katexco Pharmaceuticals Corp. operates as medical marijuana company that engages in the development of orally available therapies harnessing endocannabinoid and nicotine receptors to treat inflammatory diseases. The company was founded by Jonathan Rothbard, Lawrence Steinman and Marc Feldmann and is headquartered in Toronto, Canada. | Fondateur | - |
| Stanford University | Corporate Officer/Principal | 01/01/2001 |
Himalaya Therapeutics
 Himalaya Therapeutics Medical/Nursing ServicesHealth Services Himalaya Therapeutics is a Caymanian clinical-stage biotechnology company that is advancing its pipeline of novel monoclonal antibody and other protein therapeutic product candidates through clinical trials. The company is based in George Town, Cayman Islands, with operations in Taiwan and China. The company's product candidates have been developed using cab technology, which is protected by more than 500 issued and pending patents. Himalaya has two cab programs currently in phase 2 clinical testing in Taiwan\: BA3011, a novel conditionally active AXL-targeted antibody-drug conjugate (CAB-AXL-ADC), and BA3021, a novel conditionally active ROR2-targeted antibody-drug conjugate (CAB-ROR2-ADC). Himalaya has a co-development and collaboration agreement for an investigational CAB CTLA-4 antibody, BA3071, with BeiGene Ltd. for its development, manufacturing, and commercialization in Greater China. The company was founded by Carolyn Anderson Short and Jay M. Short, and the CEO is Brian Zhang. | Directeur/Membre du Conseil | - |
180 Life Corp.
 180 Life Corp. Pharmaceuticals: MajorHealth Technology 180 Life Sciences Corp. engages in manufacture of pharmaceutical products. The company is headquartered in New York. | Président | 14/05/2019 |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
| ░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Lawrence Steinman
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Lawrence Steinman
| Dartmouth College | Undergraduate Degree |
| Hasselt University | Doctorate Degree |
| Harvard Medical School | Doctorate Degree |
| University of Buenos Aires School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| ATRECA, INC. | Health Technology |
| BIOATLA, INC. | Health Technology |
| PHARNEXT SCA | Health Technology |
| 180 LIFE SCIENCES CORP. | Health Technology |
| Entreprise privées | 15 |
|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Bayhill Therapeutics, Inc.
 Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Health Technology |
Neuronyx, Inc.
 Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Health Technology |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Commercial Services |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Commercial Services |
Nuon Therapeutics, Inc.
 Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nuon Therapeutics Inc. develops therapies to treat inflammation and neurological diseases. The company focuses on the development and commercialization of new therapies for autoimmune disease and inflammation includes rheumatoid arthritis and multiple sclerosis. Nuon Therapeutics was founded by Kim Puloma Kamdar, Marc Feldmann, Lawrence J. Steinman and Michael Selley in 2006 and is headquartered in San Mateo, CA. | Health Technology |
Tolerion, Inc.
 Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Tolerion, Inc. operates as a clinical-stage biopharmaceutical firm. It develops and commercializes therapeutics. The firm provides TOL-3034 and TOL-3052 to treat myasthenia gravis and neuromyelitis optica. The company was founded by Lawrence J. Steinman and is headquartered in South San Francisco, CA. | Health Technology |
KBL Merger Corp. IV
 KBL Merger Corp. IV Financial ConglomeratesFinance KBL Merger Corp. IV is a blank check company, which focuses on acquiring an operating company in the healthcare and related wellness industry. The company was founded on September 7, 2016 and is headquartered in New York, NY. | Finance |
Drumroll Health, Inc.
 Drumroll Health, Inc. Miscellaneous Commercial ServicesCommercial Services Transparency Life Sciences, Inc. operates as a digital drug development services company. The firm engages in conducting research in biotechnology. The company was founded by Tomasz Sablinski and Marc Foster and is headquartered in New York, NY. | Commercial Services |
CannBioRex Pharmaceuticals Corp.
 CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology CannBioRex Pharmaceuticals Corp. is a research company that specializes in the clinical development of synthetic pharmaceutical grade cannabinoid compounds for the treatment in rheumatoid arthritis and related arthritic diseases. It also plans to develop novel orally available and patentable medications to treat arthritis, multiple sclerosis, diabetes, psoriasis, obesity and fatty liver, and various painful conditions. The company was founded by Marc Feldmann and Raphael Mechoulam on March 8, 2018 and is headquartered in Toronto, Canada. | Health Technology |
| Steinman Laboratory | |
Katexco Pharmaceuticals Corp.
Katexco Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Katexco Pharmaceuticals Corp. operates as medical marijuana company that engages in the development of orally available therapies harnessing endocannabinoid and nicotine receptors to treat inflammatory diseases. The company was founded by Jonathan Rothbard, Lawrence Steinman and Marc Feldmann and is headquartered in Toronto, Canada. | Health Technology |
180 Life Corp.
180 Life Corp. Pharmaceuticals: MajorHealth Technology 180 Life Sciences Corp. engages in manufacture of pharmaceutical products. The company is headquartered in New York. | Health Technology |
| Pasithea Therapeutics Corp. | |
Himalaya Therapeutics
Himalaya Therapeutics Medical/Nursing ServicesHealth Services Himalaya Therapeutics is a Caymanian clinical-stage biotechnology company that is advancing its pipeline of novel monoclonal antibody and other protein therapeutic product candidates through clinical trials. The company is based in George Town, Cayman Islands, with operations in Taiwan and China. The company's product candidates have been developed using cab technology, which is protected by more than 500 issued and pending patents. Himalaya has two cab programs currently in phase 2 clinical testing in Taiwan\: BA3011, a novel conditionally active AXL-targeted antibody-drug conjugate (CAB-AXL-ADC), and BA3021, a novel conditionally active ROR2-targeted antibody-drug conjugate (CAB-ROR2-ADC). Himalaya has a co-development and collaboration agreement for an investigational CAB CTLA-4 antibody, BA3071, with BeiGene Ltd. for its development, manufacturing, and commercialization in Greater China. The company was founded by Carolyn Anderson Short and Jay M. Short, and the CEO is Brian Zhang. | Health Services |
